ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,315.60
0.44%
Dow Jones
38,386.09
0.38%
Brent Oil
87.035
-0.29%
Bitcoin
64,564.75
1.14%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) News

AGY

Allergy Therapeutics (AGY)

Allergy Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGY
DateTimeSourceHeadlineSymbolCompany
04/03/20242:00AMRNS Regulatory NewsAllergy Therapeutics PLC Director ResignationLSE:AGYAllergy Therapeutics Plc
03/27/202412:13PMAlliance NewsAlliance NewsEARNINGS AND TRADING: Solid State ups outlook; Quartix trading in lineLSE:AGYAllergy Therapeutics Plc
03/27/20243:00AMRNS Regulatory NewsAllergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023LSE:AGYAllergy Therapeutics Plc
03/27/20243:00AMRNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
03/12/202410:06AMAlliance NewsAlliance NewsAllergy Therapeutics starts dosing patients in peanut allergy trialLSE:AGYAllergy Therapeutics Plc
03/12/20244:59AMRNS Regulatory NewsAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
03/12/20243:00AMRNS Non-RegulatoryAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
03/11/20243:00AMRNS Regulatory NewsAllergy Therapeutics PLC Appointment of Shaun Furlong to Board of DirectorsLSE:AGYAllergy Therapeutics Plc
03/08/20248:49AMRNS Regulatory NewsAllergy Therapeutics PLC Result of AGMLSE:AGYAllergy Therapeutics Plc
02/14/20245:22AMAlliance NewsAlliance NewsAllergy Therapeutics forecasts revenue drop but trials going wellLSE:AGYAllergy Therapeutics Plc
02/14/20242:00AMRNS Regulatory NewsAllergy Therapeutics PLC Half-Year Trading Update 2024LSE:AGYAllergy Therapeutics Plc
02/09/202410:07AMRNS Regulatory NewsAllergy Therapeutics PLC Notice of 2023 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
01/30/20245:38AMAlliance NewsAlliance NewsAllergy Therapeutics resumes trading on AIM; annual revenue plungesLSE:AGYAllergy Therapeutics Plc
01/30/20242:30AMRNS Regulatory NewsAIM Restoration - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
01/30/20242:00AMRNS Regulatory NewsAllergy Therapeutics PLC Publication of Annual Report and Accounts 2023LSE:AGYAllergy Therapeutics Plc
01/04/20247:29AMUK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
01/02/20242:30AMUK RegulatoryAIM Suspension - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
12/27/20239:17AMAlliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics amends facility, plans warrant issueLSE:AGYAllergy Therapeutics Plc
12/27/20237:01AMUK RegulatoryAllergy Therapeutics PLC Amendment to existing Facility AgreementLSE:AGYAllergy Therapeutics Plc
12/15/20234:09PMAlliance NewsAlliance NewsEARNINGS AND TRADING: Redx full year revenue tumbles; loss widensLSE:AGYAllergy Therapeutics Plc
12/15/20237:48AMUK RegulatoryAllergy Therapeutics PLC Annual Report and Accounts DelayedLSE:AGYAllergy Therapeutics Plc
12/13/202311:54AMUK RegulatoryAllergy Therapeutics PLC PDMR dealing and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
12/13/20235:11AMAlliance NewsAlliance NewsAllergy Therapeutics shares jump as hails grass allergy jab dataLSE:AGYAllergy Therapeutics Plc
12/13/20232:00AMUK RegulatoryAllergy Therapeutics PLC G306 Phase III trial meets key endpointsLSE:AGYAllergy Therapeutics Plc
12/11/20235:40AMAlliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics stock falls on lower sales outlookLSE:AGYAllergy Therapeutics Plc
12/11/20232:00AMUK RegulatoryAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
12/01/20232:00AMUK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
11/28/202310:03AMUK RegulatoryAllergy Therapeutics PLC Holding(s) in CompanyLSE:AGYAllergy Therapeutics Plc
11/14/20236:56AMAlliance NewsAlliance NewsAllergy Therapeutics says allergy therapy trial meets primary endpointLSE:AGYAllergy Therapeutics Plc
11/14/20232:00AMUK RegulatoryAllergy Therapeutics PLC G306 Grass Phase III trial meets primary endpointLSE:AGYAllergy Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AGY

Your Recent History

USOTC
RONN
Ronn Motor (PK)
USOTC
ACRL
Atacama Resources (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
ILST
International Star (PK)
NASDAQ
PLUG
Plug Power
USOTC
NSAV
Net Savings Link (PK)
USOTC
TONR
Tonner One World (PK)
USOTC
DKSC
Dakshidin (PK)
USOTC
AHRO
Authentic (CE)
COIN
SHIBUSD
SHIBA INU
USOTC
KEGS
1812 Brewing (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
NB
NioCorp Developments
USOTC
CNNA
Cann American (CE)
NASDAQ
TSLA
Tesla
USOTC
XALL
Xalles (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved